A Phase I, Single-Ascending-Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS-2969b, a Novel GyrB Inhibitor

2018 ◽  
Vol 58 (12) ◽  
pp. 1557-1565 ◽  
Author(s):  
Justin Dennie ◽  
Alexander G. Vandell ◽  
Satoshi Inoue ◽  
Roohi Gajee ◽  
Joseph Pav ◽  
...  
Keyword(s):  
Phase I ◽  
Healthy Subjects ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Dose Study ◽  
Single Ascending Dose Study

scholarly journals A Double‐Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects

2019 ◽  
Vol 13 (2) ◽  
pp. 337-344 ◽  
Author(s):  
Azra Hussaini ◽  
Rajat Mukherjee ◽  
Dina M. Berdieva ◽  
Christen Glogowski ◽  
Richard Mountfield ◽  
...  
Keyword(s):  
Phase I ◽  
Healthy Subjects ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Double Blind ◽  
Dose Study ◽  
Single Ascending Dose Study

A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056)

2012 ◽  
Vol 115 (2) ◽  
pp. 274-283 ◽  
Author(s):  
Laurie J. Antonik ◽  
D. Ronald Goldwater ◽  
Gavin J. Kilpatrick ◽  
Gary S. Tilbrook ◽  
Keith M. Borkett
Keyword(s):  
Phase I ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Dose Study ◽  
Single Ascending Dose Study

107-LB: Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1092 in Healthy Subjects (HS)

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 107-LB
Author(s):  
LINDA MORROW ◽  
MICHAEL GRIMM ◽  
CARINE BEYSEN ◽  
GEOFFREY WALFORD ◽  
KELLY DUNCAN ◽  
...  
Keyword(s):  
Healthy Subjects ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Dose Study ◽  
Single Ascending Dose Study
Sign in / Sign up

Export Citation Format

Share Document